After the emergence of multidrug-resistant Shigella strains (8, 11), fluoroquinolones, such as ciprofloxacin and norfloxacin, were used in India to treat shigellosis. However, recently, genetically clonal ciprofloxacin-resistant Shigella dysenteriae serotype 1 strains have been isolated from sporadic and epidemic cases of dysentery in southern Asia, including eastern India (1, 9, 12; S. Dutta, A. Ghosh, K. Ghosh, D. Dutta, S. K. Bhattacharya, G. B. Nair, and S.-I. Yoshida, Letter, J. Clin. Microbiol. 41:5833-5834, 2003).
No takes yet. Share an insight, caveat, or question.
Dutta et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: